| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2014 | EP2753610A2 Crystalline forms of cabazitaxel |
| 07/16/2014 | EP2753609A1 Benzothiazolone compound |
| 07/16/2014 | EP2753608A1 3-(4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1 phosphate receptors modulators |
| 07/16/2014 | EP2753606A1 Pyrimidines as sodium channel blockers |
| 07/16/2014 | EP2753604A1 Pde10 modulators |
| 07/16/2014 | EP2753603A1 Polymorphic form of pridopidine hydrochloride |
| 07/16/2014 | EP2753599A1 Biphenyl compounds for use in treating malaria and other parasitic disorders |
| 07/16/2014 | EP2753363A2 Compositions comprising mg53 and methods for the treatment and prevention of airway injury |
| 07/16/2014 | EP2753341A1 Antimicrobial compositions and uses thereof |
| 07/16/2014 | EP2753339A1 Capture of pathogenic and non-pathogenic biopolymers and bioparticles |
| 07/16/2014 | EP2753338A1 Pharmaceutical compositions containing carboxylated starch |
| 07/16/2014 | EP2753337A1 Compositions including beta-glucans and methods of use |
| 07/16/2014 | EP2753336A1 Compositions comprising s-adenosylmethionine and a gallic acid ester |
| 07/16/2014 | EP2753335A1 An anthracycline for the treatment of sepsis |
| 07/16/2014 | EP2753334A2 Fap-activated proteasome inhibitors for treating solid tumors |
| 07/16/2014 | EP2753333A1 Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies |
| 07/16/2014 | EP2753332A2 Composition for reducing skin wrinkles including pde5 inhibitor |
| 07/16/2014 | EP2753331A1 Use of 1h-quinazoline- 2, 4 -diones for use in the prevention or treatment photosensitive epilepsy |
| 07/16/2014 | EP2753330A1 Therapeutic uses of ectoin |
| 07/16/2014 | EP2753329A2 1,5-naphthyridine derivatives and melk inhibitors containing the same |
| 07/16/2014 | EP2753328A1 Dpp-iv inhibitor formulations |
| 07/16/2014 | EP2753327A2 Amido compounds as ror-gamma-tmodulators and uses thereof |
| 07/16/2014 | EP2753326A2 Methods for treating intrapulmonary infections |
| 07/16/2014 | EP2753325A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases |
| 07/16/2014 | EP2753324A1 Lipophilic dopamine derivatives and their use |
| 07/16/2014 | EP2753323A1 Treating cough and tussive attacks |
| 07/16/2014 | EP2753322A1 Scheme for administering n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide |
| 07/16/2014 | EP2753321A1 Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
| 07/16/2014 | EP2753320A1 Use of adamantane derivatives for the treatment of actinic keratosis |
| 07/16/2014 | EP2753319A1 A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof |
| 07/16/2014 | EP2753318A1 Fish anesthetic and method |
| 07/16/2014 | EP2753317A1 TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES |
| 07/16/2014 | EP2753316A1 Pharmaceutical combination comprising a cip2a silencing agent for use in the treatment of a hyperproliferative disorder, preferably one with impaired p53 function |
| 07/16/2014 | EP2753315A1 Means and methods for treating and/or preventing natural ahr ligand-dependent cancer |
| 07/16/2014 | EP2753314A1 Compositions of efavirenz |
| 07/16/2014 | EP2753313A1 Pharmaceutical compositions comprising an aromatase inhibitor |
| 07/16/2014 | EP2753312A1 Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases |
| 07/16/2014 | EP2753308A1 Compositions of lopinavir and ritonavir |
| 07/16/2014 | EP2753307A1 Compositions of lopinavir |
| 07/16/2014 | EP2753305A1 Coated suppositories |
| 07/16/2014 | EP2753304A1 Oral suspension |
| 07/16/2014 | EP2753303A1 Silicone coated implants |
| 07/16/2014 | EP2753302A1 Pharmaceutical invention of tapentadol |
| 07/16/2014 | EP2753191A1 Use of infant formula with large lipid globules |
| 07/16/2014 | EP2753190A1 Use of infant formula with cholesterol |
| 07/16/2014 | EP2753176A1 Hiv inhibitors |
| 07/16/2014 | EP2753175A1 Chiral compounds of varying conformational rigidity and methods of synthesis |
| 07/16/2014 | EP2753174A1 Certain chemical entities, compositions, and methods |
| 07/16/2014 | CN1890221B 1-n-苯基-氨基-1h-咪唑衍生物和含有它们的医药组合物 1-n- phenyl - amino -1h- imidazole derivatives and pharmaceutical compositions containing them |
| 07/16/2014 | CN103930545A 淀粉样蛋白球体结合并诱发成熟神经细胞死亡的靶向分子、用于抑制淀粉样蛋白球体诱导的神经细胞死亡的方法和物质以及它们的用途 Binding and amylospheroids induce neuronal cell death of mature targeting molecules, methods and materials for inhibiting amyloid-induced neuronal cell death spheres and their use |
| 07/16/2014 | CN103930428A 用作糖苷酶抑制剂的吡喃并[3,2-d][1,3]噻唑 Used as a glycosidase inhibitor pyrano [3,2-d] [1,3] thiazole |
| 07/16/2014 | CN103930427A 大环flt3 激酶抑制剂 Macrocyclic kinase inhibitors flt3 |
| 07/16/2014 | CN103930426A 作为大麻素受体2激动剂的[1，2，3]三唑并[4，5-d]嘧啶衍生物 As cannabinoid receptor 2 agonist [1,2,3] triazolo [4,5-d] pyrimidine derivatives |
| 07/16/2014 | CN103930424A 作为c-Kit激酶抑制剂的化合物和组合物 As the compounds and compositions of c-Kit kinase inhibitor |
| 07/16/2014 | CN103930423A 吡唑并喹啉衍生物 Pyrazolo quinoline derivative |
| 07/16/2014 | CN103930422A 杂环化合物及其用途 Heterocyclic compounds and their use |
| 07/16/2014 | CN103930421A 取代的4,5,6,7-四氢-1H-吡唑并[4,3-c]吡啶、它们作为药物的用途和包含它们的药物制剂 Substituted 4,5,6,7-tetrahydro -1H- pyrazolo [4,3-c] pyridine, and their use as medicaments pharmaceutical formulations containing them |
| 07/16/2014 | CN103930420A 茚满基取代的4,5,6,7-四氢-1H-吡唑并[4,3-c]吡啶、它们作为药物的用途和包含它们的药物制剂 Indan-substituted 4,5,6,7-tetrahydro -1H- pyrazolo [4,3-c] pyridine, and their use as medicaments pharmaceutical formulations containing them |
| 07/16/2014 | CN103930419A 阿齐沙坦的晶型及其制备方法 Azilsartan crystal type and preparation method |
| 07/16/2014 | CN103930416A 作为激酶抑制剂的苄腈衍生物 Benzonitrile derivatives as kinase inhibitors |
| 07/16/2014 | CN103930415A 泛素特异性蛋白酶7的选择性和可逆性抑制剂 Ubiquitin-specific protease selective and reversible inhibitor of 7 |
| 07/16/2014 | CN103930414A 7-{(3s,4s)-3-[(环丙基氨基)甲基]-4-氟吡咯烷-1-基}-6-氟-1-(2-氟乙基)-8-甲氧基-4-氧-1,4-二氢喹啉-3-羧酸晶体 7 - {(3s, 4s) -3 - [(cyclopropylamino) methyl] -4-fluoro-pyrrolidin-1-yl} -6-fluoro-1- (2-fluoroethyl) 8- oxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid crystals |
| 07/16/2014 | CN103930409A 芳香性酰胺基噻唑、含有它的化妆或皮肤科制剂以及它们的克服和预防不期望的皮肤色素沉着的用途 Aromatic amide thiazole, cosmetic or dermatology containing it and their preparation, and to overcome the undesired prevention of skin pigmentation purposes |
| 07/16/2014 | CN103930408A 用于癌症治疗的吗啉基苯并三嗪 For cancer treatment morpholine benzene and triazine |
| 07/16/2014 | CN103930407A 用作激酶活性调节剂的氨基嘧啶衍生物 Modulators of kinase activity is used as an amino pyrimidine derivative |
| 07/16/2014 | CN103930406A 作为gpbar1激动剂的1-哒嗪基-羟基亚氨基-3-苯基-丙烷类 As gpbar1 agonist 1- pyridazinyl - hydroxy-3-phenyl - propane category |
| 07/16/2014 | CN103930404A 用于抗疟疾治疗方法的取代的2-烷基-1-氧代-n-苯基-3-杂芳基-1,2,3,4-四氢异喹啉-4-酰胺 2-alkyl substituted-1-oxo antimalarial treatment method for -n- phenyl-3-heteroaryl-1,2,3,4-tetrahydro-isoquinoline-4-carboxamide |
| 07/16/2014 | CN103930401A 杀虫化合物 Insecticidal compounds |
| 07/16/2014 | CN103930399A 包含亚氨基亚磺酰基的二取代的5-氟嘧啶衍生物 Di-substituted derivatives of 5-fluoro-pyrimidine containing imino sulfinyl group |
| 07/16/2014 | CN103930166A p62小分子化学抑制剂 small molecule chemical inhibitors of p62 |
| 07/16/2014 | CN103930126A Tnf超家族三聚化的抑制剂 Tnf superfamily trimeric inhibitors |
| 07/16/2014 | CN103930120A 用于治疗耐多种药物的疟疾的组合物和方法 Multiple drug-resistant malaria treatment compositions and methods for |
| 07/16/2014 | CN103930116A 治疗慢性鼻及鼻窦炎的脂质缀合物 Treatment of chronic rhinosinusitis lipid conjugates |
| 07/16/2014 | CN103930115A 药物纳米粒组合物 Pharmaceutical compositions of nanoparticles |
| 07/16/2014 | CN103930114A 给药和治疗方法 The method of administration and the treatment |
| 07/16/2014 | CN103930113A 用于预防和治疗非小细胞肺癌的包含吡嗪并三嗪衍生物的组合物 Compositions for the prevention and treatment of non-small cell lung cancer included pyrazino triazine derivatives |
| 07/16/2014 | CN103930112A 预测对α7烟碱型乙酰胆碱受体激活剂疗法的响应的生物标志物 Prediction for α7 nicotinic acetylcholine receptor activator therapy response biomarkers |
| 07/16/2014 | CN103930111A 包含c-met拮抗剂和b-raf拮抗剂的组合治疗 Contains the c-met antagonist and b-raf antagonist combination therapy |
| 07/16/2014 | CN103930110A 吡咯并喹啉基-吡咯烷-2,5-二酮制剂及制备和使用所述制剂的方法 Pyrrolo-quinoline group - pyrrolidine-2,5-dione and its preparation method and use of the formulation of the preparation |
| 07/16/2014 | CN103930109A N-取代的杂环基酰胺 N- substituted heterocyclic amide |
| 07/16/2014 | CN103930108A 用于治疗眼睛疾病和病症的(细菌)叶绿素光敏剂 (Bacteria) chlorophyll photosensitizer for treatment of ocular diseases and disorders |
| 07/16/2014 | CN103930107A 青蒿氧烷和哌喹的稳定剂型 Artemisia annua siloxane and piperaquine stable dosage forms |
| 07/16/2014 | CN103930106A 中枢神经变性疾病的改善和/或治疗用组合物 Degenerative diseases of the central nervous system to improve and / or therapeutic composition |
| 07/16/2014 | CN103930105A 2-(n,n-二甲基氨基)-丙酸十二烷基酯的活性对映体 2- (n, n- dimethylamino) - propionic acid dodecyl ester of the active enantiomer |
| 07/16/2014 | CN103930104A 脂肪酸组合物 Fatty acid composition |
| 07/16/2014 | CN103930103A 移植器官的成活促进剂 Survival of transplanted organs accelerator |
| 07/16/2014 | CN103930102A 含水贴剂 Aqueous patch |
| 07/16/2014 | CN103930101A 用fty720治疗2型糖尿病 Treatment of type 2 diabetes with fty720 |
| 07/16/2014 | CN103930100A R(+)-n-甲基-炔丙基-氨基茚满 R (+) - n- methyl - propargyl - aminoindan |
| 07/16/2014 | CN103930099A 美金刚胺和巴氯芬的治疗组合以及含有该组合的药物组合物 A combination of memantine and baclofen therapy and to pharmaceutical compositions containing the combination of |
| 07/16/2014 | CN103930098A 含有芬太尼及其同族体的经皮吸收制剂 Containing fentanyl and its congeners percutaneous absorption preparation |
| 07/16/2014 | CN103929980A 含有高sn-2棕榈酸酯和低聚果糖的婴儿配方乳 Baby containing high sn-2 palmitic acid ester of formula milk and oligofructose |
| 07/16/2014 | CN103929965A 治疗方法 Treatment methods |
| 07/16/2014 | CN103929963A 吲唑-3-羧酰胺及其作为WNT/β-CATENIN信号传导通路抑制剂的用途 Indole-3-carboxamide and its use as WNT / β-CATENIN signaling pathway inhibitor use |
| 07/16/2014 | CN103929961A 化合物及其治疗应用 Compounds and their therapeutic applications |
| 07/16/2014 | CN103923812A 玛咖酒 Maca wine |
| 07/16/2014 | CN103923310A 一种接枝蒽环类抗生素的树枝状聚合物的制备和用途 Preparation and use of a graft anthracycline dendrimers |
| 07/16/2014 | CN103923256A 叶酸-苯甲醛氮芥-hpma高分子共聚物及其制备和应用 Folic acid - benzaldehyde mustard -hpma copolymers and their preparation and application of polymer |
| 07/16/2014 | CN103923160A 红毛走马胎苷及其医药用途 Orang cursory tire glycosides and medical use |
| 07/16/2014 | CN103923156A 具有保肝作用的皂苷化合物及其应用 Saponin compounds having hepatoprotective effect and its application |